Disease modeling hypertrophic cardiomyopathy using CRISPR/Cas9 genome editing technology in human pluripotent stem cell-derived cardiomyocytes
Hypertrophic cardiomyopathy (HCM) is a prevalent genetic cardiovascular disease affecting 1:500 individuals whose cardiac function is deteriorated due to thickening of the left ventricle of the heart, mostly owing to mutations in sarcomeric genes. Modeling HCM in vitro using human pluripotent stem c...
| Main Author: | Mosqueira, Diogo |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/51359/ |
Similar Items
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
by: Mosqueira, Diogo, et al.
Published: (2018)
by: Mosqueira, Diogo, et al.
Published: (2018)
CRISPR-Cas9 gene targeting of human induced pluripotent stem cells to generate a palette of optical reporter cell lines towards investigating hypertrophic cardiomyopathy
by: Bhagwan, Jamie R.
Published: (2018)
by: Bhagwan, Jamie R.
Published: (2018)
Simplified footprint-free Cas9/CRISPR editing of cardiac-associated genes in human pluripotent stem cells
by: Kondrashov, Alexander, et al.
Published: (2018)
by: Kondrashov, Alexander, et al.
Published: (2018)
CRISPR-Cas9-mediated genome editing of the extracellular matrix gene TNC in human fibroblasts
by: Brunetti, Giulio
Published: (2017)
by: Brunetti, Giulio
Published: (2017)
Investigation of CRISPR-Cas adaptation mechanism through exploration of Cas4-1 fusions
by: Walker, Emily
Published: (2019)
by: Walker, Emily
Published: (2019)
Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3
by: Gong, Bei, et al.
Published: (2014)
by: Gong, Bei, et al.
Published: (2014)
Can human pluripotent stem cell-derived cardiomyocytes advance understanding of muscular dystrophies?
by: Kalra, Spandan, et al.
Published: (2016)
by: Kalra, Spandan, et al.
Published: (2016)
Linking molecular targets to hypertrophic cardiomyopathy using genome-edited human induced pluripotent stem cell cardiomyocytes
by: Bodbin, S.E.
Published: (2022)
by: Bodbin, S.E.
Published: (2022)
Characterising Host Factors Required for CRISPR Cas Adaptation in Escherichia coli
by: Edwards, Harry
Published: (2023)
by: Edwards, Harry
Published: (2023)
Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform
by: Denning, Chris, et al.
Published: (2016)
by: Denning, Chris, et al.
Published: (2016)
CRISPR-Cas immunity: analysis of adaptation and interference reactions in prokaryotes
by: Cass, S.D.B.
Published: (2016)
by: Cass, S.D.B.
Published: (2016)
Evaluating human induced pluripotent stem cell-derived cardiomyocytes for commercial drug testing
by: Katili, Puspita Anggraini
Published: (2020)
by: Katili, Puspita Anggraini
Published: (2020)
Analysis of the E. coli CRISPR Cas3 protein and its potential for regulation by a short non-coding RNA
by: Kennerdale, Niamh
Published: (2024)
by: Kennerdale, Niamh
Published: (2024)
Using human induced pluripotent stem cells to study the in vitro phenotype of the cardiac channelopathies
by: Duncan, Gary
Published: (2017)
by: Duncan, Gary
Published: (2017)
The role of Cas8 in type I CRISPR interference
by: Cass, Simon, et al.
Published: (2015)
by: Cass, Simon, et al.
Published: (2015)
Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS
by: Majsec, Kristina, et al.
Published: (2016)
by: Majsec, Kristina, et al.
Published: (2016)
Analysis of Cas1-2 and Cas3 CRISPR immunity proteins in
E. coli cell physiology
by: Reeves, Ryan Peter
Published: (2019)
by: Reeves, Ryan Peter
Published: (2019)
Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs
by: Bertero, Alessandro, et al.
Published: (2016)
by: Bertero, Alessandro, et al.
Published: (2016)
Gene editing the phytoene desaturase alleles of Cavendish banana using CRISPR/Cas9
by: Eftekhari, Fatima, et al.
Published: (2018)
by: Eftekhari, Fatima, et al.
Published: (2018)
Genetics of human and canine dilated cardiomyopathy
by: Simpson, Siobhan, et al.
Published: (2015)
by: Simpson, Siobhan, et al.
Published: (2015)
Genetic screens in intestinal organoid (mini-gut) culture using CRISPR-Cas-9 System and studying the role of FBXL5 in colorectal cancer cells
by: Jinks, Nicholas
Published: (2022)
by: Jinks, Nicholas
Published: (2022)
MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo
by: Sala, L., et al.
Published: (2017)
by: Sala, L., et al.
Published: (2017)
Applications of a high-throughput screen detecting CRISPR-Cas spacer acquisition
by: Cannon, Christopher
Published: (2025)
by: Cannon, Christopher
Published: (2025)
Engineered human pluripotent stem cell derived cardiomyocyte platforms to detect cardiovascular safety liabilities
by: Firth, Karl
Published: (2017)
by: Firth, Karl
Published: (2017)
Human pluripotent stem cells derived-cardiomyocytes (hPSC-CMs) to assess the impact of drug- and gene-induced changes on cell function
by: Mohd Yusof, Nurul Ain Nasim
Published: (2020)
by: Mohd Yusof, Nurul Ain Nasim
Published: (2020)
Building 3D architectures for cardiomyocytes
by: Turgut, Aylin
Published: (2021)
by: Turgut, Aylin
Published: (2021)
Multiple species comparison of cardiac troponin T and dystrophin: unravelling the DNA behind dilated cardiomyopathy
by: England, Jennifer, et al.
Published: (2017)
by: England, Jennifer, et al.
Published: (2017)
Development of molecular tools for optimisation of C1 gas fermentation in acetogens
by: Rowe, Peter
Published: (2018)
by: Rowe, Peter
Published: (2018)
Investigating a human DNA repair helicase that supports CRISPR editing
by: Cubbon, Andrew
Published: (2022)
by: Cubbon, Andrew
Published: (2022)
Automation and scale-up of human induced pluripotent stem cell models of cardiovascular disease for drug screening
by: Crutchley, James E.B.
Published: (2016)
by: Crutchley, James E.B.
Published: (2016)
Current status of drug screening and disease modelling in human pluripotent stem cells
by: Rajamohan, Divya, et al.
Published: (2013)
by: Rajamohan, Divya, et al.
Published: (2013)
A predictive model for canine dilated cardiomyopathy: a meta-analysis of Doberman Pinscher data
by: Simpson, Siobhan, et al.
Published: (2015)
by: Simpson, Siobhan, et al.
Published: (2015)
Expansion of the genome editing toolbox of Clostridium autoethanogenum
by: Seys, François M.
Published: (2022)
by: Seys, François M.
Published: (2022)
Part A: Application of fluorescent markers onto CRISPR-associated proteins/ Part B: Substitution of cysteine residues in CRISPR associated Protein Cas1
by: Parr, Lochlan
Published: (2024)
by: Parr, Lochlan
Published: (2024)
Generation of mouse induced pluripotent stem cells using polycistronic lentiviral vector in feeder - and serum-free culture
by: Mahmaud, Akram Faisal
Published: (2015)
by: Mahmaud, Akram Faisal
Published: (2015)
Acetylation of TBX5 by KAT2B and KAT2A regulates heart and limb development
by: Ghosh, Tushar K., et al.
Published: (2018)
by: Ghosh, Tushar K., et al.
Published: (2018)
RNA-guided integration of diverse DNA molecules by casposase-Cas9 fusions
by: Lau, Chun H.
Published: (2020)
by: Lau, Chun H.
Published: (2020)
The effects of undernutrition and dexamethasone treatment on cultured rat neonatal cardiomyocytes
by: Austin, Ruth Marie
Published: (2010)
by: Austin, Ruth Marie
Published: (2010)
Development of Genetic Tools for the Chemolithoautotroph C. metallidurans CH34: Harnessing Synthetic Biology to Expand Knowledge of Extracellular Electron Transfer
by: Turco, Federico
Published: (2022)
by: Turco, Federico
Published: (2022)
The effect of hypoxia and reoxygenation on STAT3 regulation in potential cardiomyocyte models
by: Evans, Emma Louise
Published: (2012)
by: Evans, Emma Louise
Published: (2012)
Similar Items
-
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy
by: Mosqueira, Diogo, et al.
Published: (2018) -
CRISPR-Cas9 gene targeting of human induced pluripotent stem cells to generate a palette of optical reporter cell lines towards investigating hypertrophic cardiomyopathy
by: Bhagwan, Jamie R.
Published: (2018) -
Simplified footprint-free Cas9/CRISPR editing of cardiac-associated genes in human pluripotent stem cells
by: Kondrashov, Alexander, et al.
Published: (2018) -
CRISPR-Cas9-mediated genome editing of the extracellular matrix gene TNC in human fibroblasts
by: Brunetti, Giulio
Published: (2017) -
Investigation of CRISPR-Cas adaptation mechanism through exploration of Cas4-1 fusions
by: Walker, Emily
Published: (2019)